The January 28 meeting with the new IRB, at which Dr. Michael Mithoefer and Rick Doblin, Ph.D. appeared in person, involved a series of thoughtful questions about protocol design, risk assessment, confidentiality …
CBS News "Eye on America" report about Erowid, featuring an interview with Rick Doblin. 28.8k (1.9 MB) | 56k (3.1 MB) | Cable/DSL (13.1 MB) MPEG video: "Eye on America" — …
MAPS submitted a series of documents today to the IRC-IRB, in response to their initial comments about the protocol which MAPS received on January 6. These documents represent a very substantial amount …
Today, MAPS received the initial set of comments of the IRC-IRB. My initial impression is that we will eventually be able to get some protocol approved, but that we might need to limit enrollment to more …
The half-hour interview is in three parts: Part 1 (below), Part 2, and Part 3. Originally appearing here. …
MAPS submitted the MDMA/PTSD protocol for review to the Independent Review Consulting Institutional Review Board (IRC-IRB), with the protocol to be discussed by the review board on January 2, 2003. Officials …
On November 20, after the Western IRB decided not to review MAPS’ MDMA/PTSD protocol, Rick Doblin spoke to James Baldwin, Ph.D., Executive Director of the Western IRB. Dr. Baldwin informed Rick that …
MAPS sent a draft of the MDMA/PTSD pilot study that MAPS is seeking to sponsor in Israel to Dr. Moshe Kotler and Dr. Jorge Gleser, Israeli Ministry of Health, for their review. MAPS’ conference on …
Ron Warren, Senior Vice President of the Western IRB, wrote a letter to Dr. Michael Mithoefer, reporting the outcome of the November 19 meeting of the WIRB’s Executive Policy Committee. The WIRB …
MAPS submitted a short letter to the Western IRB’s Executive Policy Committee, in advance of its November 19 meeting at which it will discuss its review of MAPS’ MDMA/PTSD protocol. The letter …
Dr. Donald Abrams and Dr. Ethan Russo report on their medical marijuana research at the Marijuana Policy Project (MPP)/Students for a Sensible Drug Policy (SSDP) conference in Anaheim, California. View …
This article by Time magazine discusses the potential risks and benefits of marijuana. Is Pot Good For You? Well, no. But the latest research suggests the health risk from occasional use is mild, and it …